Obtaining a transbronchial biopsy using ecobronchoscopy (EBUS) is a novel, safe and minimally invasive technique which makes it possible to have a much more detailed diagnosis without the need for invasive surgery. Therefore, biopsy by EBUS implies less risk for the patient. The combination of videobronchoscopy and ecography makes it possible to visualize a larger area and obtain a minimally invasive biopsy.

EBUS facilitates the diagnosis of diseases that affect the mediastinum, such as lung cancer.
The importance of a genetic diagnosis
Tissue samples are necessary to perform genetic analyses to determine both the prognosis and treatment of lung cancer. With the genetic information gleaned from biopsies taken by EBUS, medical oncologists can select specific treatments for each subtype of lung cancer. Such treatments are highly effective, with low toxicity and in many cases can be taken orally.

Our Interventional Pneumology & EBUS-TBNA unit is led by Dr. Pablo Rubinstein.

Dr. Rubinstein holds a degree in Medicine from Universidad de la República, Uruguay (UDELAR), specialism in Internal Medicine, a PhD in Health Sciences, International University of Catalonia and a Master’s in Healthcare Management, University of Murcia. He is currently Head of Pneumology at the HU General de Catalunya.
He has participated in respiratory disease clinical trials, publications in prestigious biomedical journals, and at scientific congresses. He is a member of SEPAR (Spanish Society for Pneumology and Thoracic Surgery), ALAT (Latin American Thorax Association), ERS (European Respiratory Society), SMU (Uruguayan Medical Syndicate), SOCAP (Catalan Society for Pneumology) and SCATT (Catalan Society for Prevention & Control of Smoking).